Veteran healthcare executive and board director focused on biopharma commercialization and corporate strategy. Kathleen Schroeder has led commercial operations, partnering with life‑sciences companies on go‑to‑market planning, pricing and market access. Known for scaling specialty sales teams, guiding M&A integration and advising PE and VC‑backed growth companies, she is active in governance and commercial due diligence for investors targeting specialty therapeutics and digital health.
Veteran healthcare executive and board director focused on biopharma commercialization and corporate strategy. Kathleen Schroeder has led commercial operations, partnering with life‑sciences companies on go‑to‑market planning, pricing and market access. Known for scaling specialty sales teams, guiding M&A integration and advising PE and VC‑backed growth companies, she is active in governance and commercial due diligence for investors targeting specialty therapeutics and digital health.
Veteran healthcare executive and board director focused on biopharma commercialization and corporate strategy. Kathleen Schroeder has led commercial operations, partnering with life‑sciences companies on go‑to‑market planning, pricing and market access. Known for scaling specialty sales teams, guiding M&A integration and advising PE and VC‑backed growth companies, she is active in governance and commercial due diligence for investors targeting specialty therapeutics and digital health.
Veteran healthcare executive and board director focused on biopharma commercialization and corporate strategy. Kathleen Schroeder has led commercial operations, partnering with life‑sciences companies on go‑to‑market planning, pricing and market access. Known for scaling specialty sales teams, guiding M&A integration and advising PE and VC‑backed growth companies, she is active in governance and commercial due diligence for investors targeting specialty therapeutics and digital health.
| Trades 122 | Longs Won 81/122 66% | Profit Factor 40.65 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.56M |
| Average Win $471,698.61 | Best Trade (Aug 15) $14.14M | Sharpe Ratio -9.85 |
| Average Loss -$22,923.83 | Worst Trade (Sep 01) -$146,011.23 | Z-Score 2.66 (99.23%) |
| Commissions $0 | Avg. Trade Length 9m 3w 6d | Expectancy $305,473.04 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.4% |
| Consecutive Losing Trades | 9,174 | 8,257 | 7,339 | 6,422 | 5,505 | 4,587 | 3,670 | 2,752 | 1,835 | 917 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
DFAC Dimensional U.S. Core Equity 2 ETF | 880,703 | $31.49M | $39.98M | - | $8.49M | 26.95% | +0.71% |
DFAT Dimensional US Targeted Value ETF | 453,835 | $25.71M | $32.45M | - | $6.74M | 26.19% | +1.606% |
DFAW Dimensional World Equity ETF | 29,159 | $1.85M | $2.48M | - | $622,984.15 | 33.64% | +0.64% |
DFAX Dimensional World ex U.S. Core Equity 2 ETF | 1.24M | $32.14M | $47.28M | - | $15.15M | 47.13% | +0.369% |
DFCF Dimensional Core Fixed Income ETF | 502,526 | $20.98M | $20.78M | - | -$196,401.54 | -0.94% | +0.085% |
DFEM Dimensional Emerging Markets Core Equity 2 ETF | 6,993 | $231,328.63 | $281,468.25 | - | $50,139.62 | 21.67% | +0.399% |
DFGX Dimensional Global ex US Core Fixed Income Fund | 257,900 | $13.57M | $13.33M | - | -$242,160.06 | -1.78% | -0.087% |
DFIC Dimensional International Core Equity Market ETF | 14,346 | $494,363.51 | $559,278.81 | - | $64,915.3 | 13.13% | +0.322% |
DFSB Dimensional Global Sustainability Fixed Income ETF | 28,869 | $1.48M | $1.46M | - | -$25,683.73 | -1.73% | 0.0 |
DFSD Dimensional Short-Duration Fixed Income ETF | 140,830 | $6.66M | $6.64M | - | -$20,869.75 | -0.31% | +0.053% |
DFSE Dimensional Emerging Markets Sustainability Core 1 ETF | 10,008 | $347,689.2 | $488,940.84 | - | $141,251.64 | 40.63% | +0.293% |
DFSI Dimensional International Sustainability Core 1 ETF | 22,710 | $791,733.88 | $1.06M | - | $267,233.42 | 33.75% | +0.237% |
DFSU Dimensional US Sustainability Core 1 ETF | 63,176 | $2.48M | $3.04M | - | $561,229.54 | 22.64% | +0.806% |
DFUS Dimensional U.S. Equity Market ETF | 314,557 | $20.66M | $26.24M | - | $5.58M | 27% | +0.475% |
DFUV Dimensional US Marketwide Value ETF | 14,834 | $607,242.79 | $850,359.05 | - | $243,116.26 | 40.04% | +0.853% |
DUSB Dimensional Ultrashort Fixed Income ETF | 217,424 | $11.02M | $11.03M | - | $15,497.07 | 0.14% | +0.049% |
GBCI Glacier Bancorp Inc. | 37,343 | $1.88M | $1.74M | - | -$137,235.63 | -7.32% | +2.658% |
PNW Pinnacle West Capital Corporation | 1,984 | $212,335 | $193,618.56 | - | -$18,716.44 | -8.81% | -0.072% |
VTI VANGUARD TOTAL STOCK MKT ETF | 654 | $209,810 | $246,401.04 | - | $36,591.04 | 17.44% | +0.424% |